Isolation and characterization Phage UPM1705 against multi-drug resistant K. pneumoniae 1705
-
Published:2021-02-04
Issue:
Volume:
Page:19-25
-
ISSN:2672-7277
-
Container-title:Asia Pacific Journal of Molecular Biology and Biotechnology
-
language:en
-
Short-container-title:APJMBB
Author:
Assafiri Omar1, Song Adelene Ai-Lian1, Hanish Irwan1, Tan Geok Hun2, Yusoff Khatijah1
Affiliation:
1. Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia 2. Department of Agriculture Technology, Faculty of Agriculture, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
Abstract
The rise in in the number of drug-resistant bacteria that can resist almost all kinds of antibiotics is due to the overuse of these antibiotics (e.g., carbapenems). Thus, there is a need to find an alternative to antibiotic treatment such as the use of phages. In this study, phage UPM1705 was isolated from a polluted lake which can lyse its host Klebsiella pneumoniae ATCC BAA-1705. Based on morphological appearance from transmission electron microscopy, UPM1705 belongs to Caudovirales (Myoviridae). UPM1705 can reach a titer of 107 PFU/ml based on the double-layer method. It has a burst size of 298 PFU/bacteria cell and a latent period of 80 min, a rise period of 75 min, and adsorption time of 20 min based on a one-step growth curve assay using an MOI of 0.02. It was stable from 4°C to 80°C and retained its functionality at pH between 4 to 11, with pH of 7 being the optimum pH for the phage growth. The efficiency of UPM1705 was tested via a turbidity assay at MOI of 0.02, 0.2, and 2. UPM1705 was able to clear the turbidity of the host bacteria culture at all of these three MOIs. Thus, UPM1705 has the potential to be used for phage therapy.
Funder
Universiti Putra Malaysia
Publisher
Malaysian Society for Molecular Biology and Biotechnology
Subject
Molecular Biology,Biotechnology
Reference37 articles.
1. Anand, T., Virmani, N., Kumar, S., Mohanty, A., Pavulraj, S., Bera, B., Vaid, R., Ahlawat, U. & Tripathi, B. 2020. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. Journal of Global Antimicrobial Resistance 21: 34-41. 2. Caldeira, J. C. & Peabody, D. S. 2007. Stability and assembly in vitro of bacteriophage PP7 virus-like particles. Journal of Nanobiotechnology 5(1): 10. 3. Cao, F., Wang, X., Wang, L., Li, Z., Che, J., Wang, L., Li, X., Cao, Z., Zhang, J., Jin, L. & Xu, Y. 2015. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. BioMed Research International 2015. 4. Chan, B. K., Abedon, S. T. & Loc-Carrillo, C. 2013. Phage cocktails and the future of phage therapy. Future Microbiology 8(6): 769-783. 5. Chandy, M. & Bhattacharya, S. 2015. The problem of multi-drug resistant Gram-negative Infections among Cancer patients in Eastern India. In 11th Indo-Australian Biotechnology Conference on Innovation in the Immunology of Infection, Cancer and Autoimmune Diseases and Vaccines 1: 7-8.
|
|